Sharp Therapeutics Private Limited - Due diligence report

A 360° intelligence report on Sharp Therapeutics Private Limited: trust score, financial health, credit view, compliance, directors, growth …

2011-02-18 Hyderabad, Telangana Strike Off Unlisted Active Non-Compliant
Share
Connect MCP
ST Sharp Therapeutics Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sharp Therapeutics Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
32/100
Trust Score
Caution Indicated

Sharp Therapeutics Private Limited is assessed as Caution Indicated with a Trust Score of 32/100. Sharp Therapeutics Private Limited is a private limited indian non-government company incorporated in 2011, operating in the Chemicals sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 13 Oct 2026 from the latest processed filings. Sharp Therapeutics Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Weak
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
32/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
5/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
15/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
35/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 5/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2017 - filings overdue.
  • Flagged by authority: MCA.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
BHASKAR REDDY ATLA 01234567 Director 01/04/2018 6 yrs Approved
SATYANARAYANA SALADI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • SATYANARAYANA SALADI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 35
Growth signals & trust indicators
Operating for 15+ years.
Distress signals & risk flags
Negative net worth.
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (5/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence22/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment26/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view33/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 5 events
30 Sep 2017
Last AGM held
Annual general meeting
31 Mar 2017
Latest balance sheet
Filed with ROC
18 Feb 2011
Incorporated
Registered with Roc Hyderabad
Director appointed
BHASKAR REDDY ATLA (Director)
Director appointed
SATYANARAYANA SALADI (Director)
10

Key Observations

Auto-generated from the data above
2 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Takecare Digital Private Limited U93000TG2020PTC141904 Hyderabad, Telangana
Ravi Illustrations Private Limited U24220AP1986PTC006949 Hyderabad, Telangana
AGRINATURE INNOVATIVE PRODUCTS LLP AAY-7583 Hyderabad, Telangana
FLIXWISER LLP AAT-7833 Hyderabad, Telangana
Sai Sankataharini Chit Funds Private Limited U65992TG1998PTC030795 Hyderabad, Telangana
Quikvik Agro Impex Private Limited U74999TG2017PTC116402 Hyderabad, Telangana
Sri Chidrupa Products Services Publications Private Limited U46305TS2024PTC180837 Hyderabad, Telangana
Bunar Welltech Engineers Private Limited U29253TG2010PTC071778 Hyderabad, Telangana
Keerthi Infotech (India) Private Limited U72900TG2008PTC062138 Hyderabad, Telangana
Kitchen Planet India Private Limited U15134TG2020PTC141860 Hyderabad, Telangana
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sharp Therapeutics Private Limited before audits and certifications: compliance score 5/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sharp Therapeutics Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 50/100, margin trends, ownership structure and peer set for Sharp Therapeutics Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 32/100, distress signals and MSME payment-delay disclosures - know whether Sharp Therapeutics Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Sharp Therapeutics Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sharp Therapeutics Private Limited an active company?

Sharp Therapeutics Private Limited has MCA status “Strike Off” with a compliance score of 5/100 (Caution Indicated).

Is Sharp Therapeutics Private Limited financially healthy?

Sharp Therapeutics Private Limited has a Financial Health Score of 15/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Sharp Therapeutics Private Limited?

Its overall Trust Score is 32/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sharp Therapeutics Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Sharp Therapeutics Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Sharp Therapeutics Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 5/100 (Caution Indicated).

Is it risky to lend to Sharp Therapeutics Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.